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Method; BIO was treated with amlodlptno (10 mg/kg/day) or nlfodlpino 
(30 mg/kg/day) ham 5 to 20 week of ago, and the aortic smooth muscle 
contractile responses te phonylephrine (Pho), anglotenaln II (A II) and high 
K* were examined, 
Results: The aortic contractions induced by Pho, All and high K* in BIO 
were significantly enhanced compared with Fib (p ~ 0,001), TreMment with 
amlo(:llplno slgnlflcnnlly suppressed the c'ontrootllo responses to Pho, All and 
high K' In BIO (p .~ 0,05), In contrast, treatment with ntfodlplno was without 
effect. 
Conclusion: Those rosullS Indicate that chronic treatment with amlodlplne 
but not nlfedlpine improves the hypemontrnctlilty el aortic smooth mgBclo in 
BIO, Amlodtplno may improve the prognosis at nonteehem~e cardlomye, pnthy 
by It# properties to be able to modify the roseolar contractility in ItoBrt Iaih~ro, 
• Adenoalne Inhibits Immediate Cerdledepresslve 
Effects of Tumor Necrosis Factor-alphas In Adult 
Cardlomyocytaa 
D,R, W~gnor. A, Combos. C, MoTlornan. A,M, Feldman, Univer:~ity of 
P~ff~burgh, Ptltsl~ff~h, PA, USA 
Backcjre~nd: Various Bludlos a.ggnat that tumor nn(.'reals lacier.alpha (TNF) 
contrlbute~ to esrdtnc dy~fun(~tion II has recently bean rocognited tl~ed TNF 
h~s ~ bipl~asi~ effent, Delayed negative inotropy ocoum alter hm, fo days 
and is nitric oxide dependent, Immediate negative inotropy occtlrs oiler 
3('1 rain, ~nd mav be spltingoslno dependant, We have previoosfy shown 
that adenosine Inhibits flpopolysaccl~nrldo (LPS)-mediated delayed cardiac 
depression In noonnt(~l myecylos, The alto ~! fhiB study was to determine 
whether adenosine s~lppre~aes immediate TNF effects, 
MethO(~: We shldled the effect o1 adenosine (1-10 I~M) on contracting 
adult rot ventrlcular myecytea stimulated for 30 rain, with TNF (200 u/tel), 
sphtngo~lne (10 I,M) or LP$ (10 u g/ml), Myocyto contraction was measured 
with video edge detection, 
RoSutI~: In controls, fractional ahertonlng (FS) was 14,3 1 0,4%, After 
eXlX~suro to TNF, sphlngostno and LPS, FS decreased by 36%, 31% and 
33%, respectively (n ,. 28, p < 0,05). Co-treatment with adenosine (10 ~M) 
significantly (n = ~B, p - 0,05) improved FS which leturnod l.~ adenosine 
baseline In the TNF, spl~tngoslne and LPS group. Baseline adenosine (10 
~,M) FS was 1~.9 :t 0,5, 13% below controls, probably through activation 
of the A~ receptor. Adenosine (1 ¢~M) completely narmalized TNF induced 
effects, presumably because of less actlvation of the A~ receptor. 
Conc/uslon: Adenosine inhibits the immediate negative inofrop=c effect of 
TNF In adult eardtemyocytes. 
• Energetic Eftect~ of  Protein Klnase C Inhibit ion 
During Calcium Induced Inotropy in the Isolated 
Pert'used Mouse Heart 
G.A MacGowan, A.E Koretsky. P~ttsburgh NMR Center for Biomed~ca/ 
Research. and Universit],, of Pittsburgh Medical Center. Pittsburgh. F~¢. USA 
L~ctckgro~md. Protein kinaso C, a Ca ~" dependent intracellular messenger, 
offocts the Ca °" sensitivity of the contractile apparatus. By modulating the 
amount of Ca "% handling required for a given developed pressure, this may 
In turn effect O~ consumption (MVO2) (energetic efficiency). 
Methods: In the isolated, Langendorft pedused mouse heart, we de- 
termined the effects of protein kinase C inhibition (PKCi) by the specific 
inhibitor, chelBq/thrine, on developed pressure (DP, mmHg) and MVO: 
(~ mole~min/g.dry weight) dunng increases in inofropy produced by increas- 
in 9 the concentration of pedusafo Ca -% . At a paced rate of 8 Hz, and with 
a balloon situated in the left ventricle, hearts were perfused for a 30 minute 
control period (Ca ~* 2,5 raM), and then received eHher Ca ~* 3.5 mM (N = 
6), or PKCi (chelerythrine 10.0 I~M) + Ca ~* 3.5 mM (N = 7) for a further 30 
minutes. All values mean ± SO. 
Results: Increasing [CaZ*J from 2.5 to 3.5 mM increased DP from 54 ~ 9 
to 66 • 9, though this was significantly attenuated by the addition ef PKCi to 
Ca ~* 3.5 mM (50 :~: 5 to 56 -J: 5, p < 0.05 vs Ca -~" 3.5 raM). However, MVO~ 
was not elfected by PKCi (Ca ~* 3.5 raM: 49 :~- 4 to 58 ~ 3 vs Ca ;* 3.5 mM 
+ PKCi: 51 ~: 3 to 58 ± 3, p = NS). Thus, the energetic efficiency associated 
with Ca ~+ induced inotropy (&DP/=~, MVO~) was decreased by PKCi (0.9 
0.4 vs 1.5 ~ 0.6, p ~ 0.05), In separate experiments, no effects of PKCi were 
seen when increasing [ Ca ~*] from 1.5 to 2.5 mM 
Conclusions: PKC mediates Ca ~* induced inotrepy and plays an important 
r(,le in de;,ermining energetic efficiency at higher levels of pertusate [Ca ~" ] in 
the isolated perfused meuse heart. 
• Progressive Molecular and Physiologic 
Remodeling In Murlne HASrts After Myocardial 
Infarction 
F.R, Eberlt, F, Sam, S, Ngoy, DL,F. Chang, C,S. Apsfoin, W,S, Colucci. 
Boston Untvemtty. MA, USA 
The molecular mochnntsms thrtt mediate myocardial remodeling {~nd failure 
are net known, Our gent was to ch~mcfonze o chronic heart f{ti!ure modal 
in CD.1 mice subioctod to myoct~rdisl Inlsrction (MI) by coronary ligntion, 
Myocardl(ll lun{~tl~n was assessed by pint, sure.volume analysis in i~o!sted 
hearts end ANF e, nd SEP, CA.2 mRNAs wore mo~sum~l by northern blot 
(xn(:l 4 weeks (~tter MI (n .. 1~) ur sham operation in '~ 9), MI Bit{) wa~ 40 ~_ 
3%, PostMI hel'lrtB Were hypertrophied vs, Shams (HW/BW ~ 6,5 ~ 0,2 vB~ 
4.9:1 0,2 rag/g,, p -. Q,O,5), Post.Mr hearts were dilated at ~t w~eks (figure A) 
and progressed at 4 wo~kB, PoBt.MI h0arts showed decreased contractile 
functton {~s assessed by LV dovqtoped pressure at any gwon pro!cad (liguro 
B)~ At 2 weeks ANF mRNA was incroas0d 5.fold in the nnn inli~rctod remote 
myocardi.m and 13,told in the berdertone. SERGA-2 was unchanged in the 
non.infamtod myocmdmm. 
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Thus, in the mouse a MI of moderato size results in progressive LV re- 
modeling at 2 and 4 weeks with chamber dilation, compensatow hypertrophy. 
reexprossion of a fatal gone (ANF), and both systohc and dlastohc myocmdial 
dysfuechon This model will allow the use ef gene.ically-englneerod mice to 
.~f-d~,, ilia mechanism of myocardial remodeling. 
• Benef ic ia l  Effect el  Phosphod les terase  Inhibitor, 
MI I r lnone on Left ~/entrlcular Relaxation in Heart 
Fai lure 
T, Tanigawa, M. Kohno, M. Yano. T Yamamoto, T. Hisaoka. K. One. 
I't Konlshi, M Matsuzaki. Yamaguchi University Ube, Japan 
l}ackgmund: Milnnono (Md) has been shown to improve LV systohc funcbon 
by its positive inotropic action in heart fadure (HF). However, It ts unclear 
whether Mtl also exerts positive lusitrepy in HF Here, we assessed the effect 
of Mil on LV contractility and relaxation in comparison with that at dobutamino 
(Dob). 
Methods: HF was produced by rapid RV pacing (250 bpm) over 4 weeks 
in 5 dogs. Md (2-20 ~g/kg) or Dob (2-10 l~gikg/min) was stepwicely admm- 
Lstored and LV pressure was measured by 8F Miller's catheter. 
Results: As compared with normal qrouo (N. 5 doqs), LV end-diastohc 
pressure was elevated in HF (6 vs 22 mmHg, p < 0.01 ). The LV peak + dP/dt 
was decreased by 18% (P - 0.01), while ftmo constant (r) of LV pressure 
decay dunng i:;ovolumic relaxation penod was increased by 36°,0 (p < 0.01) 
Either by Dab or Mil, the LV peak + dP/dt was less increased in HF than in 
N, while r decreased to a similar extent as N by Dab and even more than 
N Oy MiL In HI:. the r decreased to a greater extent (p ~ 0.05) by Mil (8%) 
than by Dab (1%) when compared at a dose by which similar increase el 
+dP/dt (5% vs 6%, respectively, ns) was obtained. Thapsigargin-sensitive 
Ca :+-ATPase activity was measured in crude hemogenate prepared from LV. 
The CaZ'-ATPase activity decreased in HF comparecl with N (0.14 vs 007 
~mol/min/mg, respectively, p .: 0.01 ). Mtl increased the Ca 2* -ATPase activity 
in a dose-dependent manner and % increase in Ca `~*-ATPa,`" -, activity by Mil 
was larger in HF than in N (Fig). 
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Conctuston: Low dose ol Md substl~n0ally improved LV relaxabon in as- 
soctahcn wtth stimulation of Ca' ~TPase activity in sarceptasm~c rot=culum 
~ - ~  Tota l  Body  En(lothclln-1 Kinetics in Normal  
Sub j . : re  end Heart Fai lure Pat ients:  A New 
Rad lo t rac~r  Approach  
A,S, Pandey, J,J Thtes~en, D J  Slowan, JD Parker Umvem~ty atToront~ 
Toronto, O.fantx C~na(/a 
Endothelin- 1 lET-t) is elevated in CHF, althoqgh lfs kmettcs are po0dy under. 
stood in humans, We descnbe a technique ot ~l-!abelled ET.t ('~l.ET~l) 
ifl~StOn tO d~femline total ~ ET-t kinol~cs. 
&l/efhOo~.~'lesu~: 5= nora',SiS and 5 CHF patients were sttMted. Over 5 
minutes, 50 m~'ocune~ 0f ~ l .E ' r . t  wore refused. Hemodynamics #lnd blood 
samples_ wel~ Obta i~ 31 limes over 240 minutes, Afler Cla col~lmn e~lrac. 
lion, plasma was counted m a gamma counter. ET-1 plasma levels were 
measorod using an enzyme Immunoassay lechn!¢l~,l~. Ki~,~,tics Of ~I.ET.1 
clearance were modelled thmu0h standard computer modelhng ~ystems 
Basehne O~cutating ET-! levels were elevated m the CHF palients [282 
106 pg.,~! vs 097 ± 043, P ~ 0.05) There were no changes in homo- 
dynam~,s Or Ctrcutatmg ET-I levels w~th "%I-ET-1 infusmn =n e0her group 
The kinettCS 01 ET-1 clearance were best descnbecl by a three compartment 
model wlfh a prolonged terminal half life (455 ¢ 59 minutes, normals; 20689 
~. 2017'2, CHF). The steady state volume et d~stnbubon was large but atg- 
nifcantly smaller in CHF patients (34.9 ~, 99 L~g vs 23.7 ± 6.4 P - 0.05) 
The elearanoe rate at ET-t from plasma was slower m CHF patmnts (0066 
0.0088 I.Jkg~mm vs 0.036 ~: 0.012, P = 0.05) 
Cor¢tusK~ns: Th~s stuo'y desc.bes a three compartment pharmacok,not~c 
profile for ET-1. Its terminal hall life and plasma volume at d~stnbuhoe are 
sign~ficantiy lan3er than ~ev~ous reports. The pharmacekinet~c profile of CHF 
pahents ~s altered and may explain ~ts elevatnd ctrCulating levels. 
~ l r h e  Neuronal  NorelPlnephrine Transpor ter  in 
IE=perimental Heart Fai lure A f te r  Supracoronary  
Aortic Banding in the  Rat  
M Haass, J. Backs, M.M. Borst. S.H Gerber. P. Szala=. L Khmaschewskl ~ ,
R.H. Strasser. Departments of Cardiology. Germany. 'Anatomy. Unn~ers~ty 
ot He,de/berg. Germany 
Background: Cardiac net secretion el norepmepnnne (NE) =s increased m 
congesbve head failure. To further elumdate the role of the neuronal nore- 
pmephnne transporter (NET, uptake~ )expenments were pefforme~ m rats 
w~th supracoronary aod=c banchng. 
Methods and ResultS: Compared to sham operated control rats. rats wtth 
aortic banding were characterized by myocardial hypertrophy (heart weight 
1 77 ± 0.08 vs. 122 ~ 0.02 g). pulmonary congest=on (7.24 .- 0 38 vs 409 : 
0.16 g). and increased plasma NE (4 4 : 0.8 vs. 3.0 = 06 nmol;0 In ~solarecl 
pedused nearts funobonal ,mpa=rment el NET was md~cated by It) the uptake 
of [3H]-NE being reduced (20 ± 1 vs. 30 z 2%) and (11) pharmacelog=cal 
blockade o1 NET wtlh aesipram~ne (DMI. 300 nmot~tl leading to a d~rmntshed 
increase in endogenous NE release evoked by electncal field stlmul0hon (4 
HZ. 1 mini ($2/Sl 1.2 ± 0.2 vs. 1 7 ~ 01: St: control: St; alter DMI} in 
:: 6, p < 0.05 each). RT-PCR was used to study NET g¢~e expression 
In situ hybndlzatton v~th the DIGJabeled PCR product revealed a dense 
hybndizaticn in the penkarya cf tyrosme hydroxylase pos=tr~e cell bodies 
w0hin the left stellate ganghon but neither in efferent car~ac nerves nor the 
head. NET mRNA concentratrons of the left stellate ganglion were quantified 
by competihve RT-PCR. as was 18S rRNA to control tar intact RNA. However. 
there was no significant difference between aodic banded and sham operated 
rats (1.65 ± 0.11 vs. 1.81 ~ 0.07 NET mRNA]18S rRNA ~ 10 ~, n = 6) 
Concluston: Cardiac NE uptake by the NET is imps=red in aortic banded 
rats with head failure despde unaltered NET gene express=on 
~ Endothe l in  Receptor  Improves  B lockade  Left 
Ventr icu lar  Pressure-Volume Relat ionships  
Without Altering the Hypertrophic Response 
During Congest ive  Heart Fa i lure in Rats 
E. Oie ~ , R, Bjomerhelm ~, H.K. Grogaard ~ . O,A. Smiseth ~. H. Attramadal ~ .
~ MSD - CVRC, Nonyay, ~ Med. Dept. B. The National Hospital University at 
Oslo. Oslo. Nonvay 
Background: The role played by endothelin-1 (ET-1) in the progression ot 
congestive heart failure (CHF) remains unknown. We investigated the effects 
of ET receptor blockade on cardiac dimensions and dynamics, and on gone 
expression markers of hypertrophy during CHF 
Methods: Alter ligation of the left coronary artery, rats were randomized 
to oral treatment with a non-selective ET receptor antagonist (Bosentan, 100 
mg/kg/day, n = 11) or saline (n = 13) for 15 days starting 24 hours after 
the tnducbon ot mycx:ardtal *ntarc1~on T0n she ,-Operated fats rece~., ' ,,o 
treatment 
Results Right venlncular wl/t:X:K~ wl tetras were incroaseo Dy 65% =~ 
both the CHF groups (p ~ 005) E~.hoca~mgrapny feveatecl an ,ncteas~ ~n 
taft ventncut~f end-O~a~tohc d~mens~orr~ (LV EDD) tram 57 • 0 1 in ~ s~'n  
group to 8,7 • 0.2 mm In the CHF-sahne group, wh*l~ tr~.'ffmnal ~
(FS) was decreased from 3~ ~ 2 to 12 z 1% (p ,: 0.05) Inteeventmn w~h 
bosentan Caused 35% red~tt0n in LV ddatatmn (LVEDD 7.6 ~ 03 ram) 
an~ 49%, increase ,n FS (to 18 z 1%) compared to vel'~cte (p ~ 005) 
Bosentan also roducect LV enc~a~ttohc PreSsgra fro~ 23 z i to 20 • 2 
mmHg and LV systole pressure from 107 ~ 3 Io 99 ~ 2 mmHQ (p ~ 0.051 
Express~on o! prepreET.1. ANP, BNP, p.MHC ar~ fikeletal ~.actin mRNAs 
were all marke~y a~d ~ignd'~csnthl mCre~od In nenq,~chem~c myoca~c~-rn ,~-~ 
CHF No drfferer~es were obsewed between the CHF gre~.  
Conclusion Intervention w=lh Bosentan dramatically improves LV pres~ 
-,ure-volume relationships and cardiac dynamics wnhout altenng the hype~, 
trophie response dunng CHF in rats 
~ ~3~ w.at le the sour~= of ,ncm~ Mwc=.d~,l ~.mo. 
Necrosis Factor-alpha In Heart Fai lure? 
GW Mo~, R Ou, A. AIb~rnaz, G Na,k, P LJu Unlversrty of Toronfc~ 
Toronto, Onlarlo, Canada 
Background Tumor necrosis factor-alpha (TNF-a) Is a pleolrep=c premftam- 
matory cytokme and plasma TNF-a level appears to cater prognosis m pa- 
tlents wnb heart fadum (CHF) However, there =s debate regar~ng the soume 
at the increased TNF-a. Some investigators argue Ihet TNF-a is produced 
by =mmune activatmn at end stage CHF. We therefore studmd TNF.a ~n a 
clog model at pacmg-~nduced CHF in which there ~s IJMle tissue tnMammah~ 
re~panse. 
Mettm~s. Six dogs were nght ventncular-paced at 250 beats~rmn mr 3 
weeks to severe CHF Senal plasma levels (mean ~ SE) of TNF-a (by 
ELISA, pcjJml} and noropmephnne (NE. by HPLC, pg/ml) are shown 
• p 0 05 versus t~aselme 
Baseline Week 1 Week 2 Week 3 
TNF-a B : 4 79 ± 27" 89 z 25' 247 ~ 98" 
NE 23? t 34 391 ~ 62 445 t 74" 644 ~ ~64" 
Results: EvoMng CHF =.~ accompanied by a progresstve increase cn 
plasma TNF-a and NE Immunohistochemical studies of the LV of the paced 
ct~gs revealed intense staining for TNF-a m the myocytes, endothehal ana 
smooth muscle layers, but not m the tibreblasts. These change.~ were not 
observed in conlrel normal d~ Staining el the spleens from the paced 
dogs were s~mffar to lhe controls 
Conclusion: Increased plasma and myocardial TNF-a m a model of CHF 
with ht~le immune pathegenes=s uggests a pnmary product=on of TNF-a ~n 
the heart without a reclu~rement of immune activation. 
~ C a  ~* From Reticulum Is Release Sarcoplasmic 
Slowed Down In Heart  Failure 
T Yamamolo. M. Yano, M Kohno. K One 1". Hisaoka, T. Tanlgawa, 
T OhkuSa. f',~. Malsuzak~. Yamaguchi UmverSrfy, Ube, Japan 
Background." In heart tadure, little informatmn is available as to the Ca ~" 
release function of SR which plays a maior role on cardiac contractility. 
Method: The SR vesicles were isolated from dog LV muscles (normal 
[N]. n = 7: pacing induced heart fadure [HF], n = 6). The lime course of 
SR Ca 2" release was car :muously monitored by a stopped-flow apparatus 
using arsen3zol[I as Ca;" indicator, and [3H]ryanoclino (Ry) binding assay 
was done using flltratmn method. 
Resu/t: As compared ~-,tth N. LV end-diastolic pressure was elevaled by 
380 • 91% (p . 001). The peak + dP/dt was decreased by 24 = 13% 
(p = 0.01) wh~le hme co, natant at LV pressure d~,.,ay dunng isovolum~c 
relaxation was increased by 19 : 8% (p - 0.01), indicating HF The amount 
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